Ontario may lift ban preventing major pharmacies from selling private-label generic drugs

21 March 2019 - Ontario Premier Doug Ford’s government is considering lifting a ban that prevents major pharmacy chains from ...

Read more →

FDA approves a new generic valsartan

12 March 2019 - Today, the U.S. FDA approved a new generic of Diovan (valsartan).  ...

Read more →

Drug price fix seen in supply of generics, rebates, Senator says

7 March 2019 - Middlemen, not consumers, get company discounts, Collins says. ...

Read more →

“Repurposing” off-patent drugs offers big hopes of new treatments

28 February 2019 - Towards the end of 2014 a 66-year-old British man named Alistair had a seizure. A scan ...

Read more →

Drug prices aren't falling despite more generics, report finds

26 February 2019 - More generic drugs are being approved in the U.S., but those copycat treatments likely aren’t having a ...

Read more →

Statement from FDA Commissioner and Director of FDA’s Center for Drug Evaluation and Research on the FDA’s continuing efforts to maintain its strong oversight of generic drug quality issues domestically and abroad

22 February 2019 - At the FDA, protecting patient and consumer health is our highest priority. Assessing and mitigating risks ...

Read more →

Indivior launches generic version of its Suboxone opioid drug

20 February 2019 - British drugmaker Indivior said on Wednesday it had launched a copycat version of its blockbuster opioid ...

Read more →

Statement from FDA Commissioner on new policy to improve access and foster price competition for drugs that face inadequate generic competition

15 February 2019 - In too many cases, branded drugs that are no longer protected by patents or other exclusivities ...

Read more →

Mylan launches Wixela Inhub (fluticasone propionate and salmeterol inhalation powder, USP), the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder), at a list price 70% less than the brand

12 February 2019 - Unique pricing of Wixela Inhub immediately benefits patients and reduces overall cost to the U.S. health care ...

Read more →

Generic drug approvals surge, but hundreds still aren't for sale

7 February 2019 - The Trump administration has been trumpeting a huge increase in FDA generic drug approvals the past ...

Read more →

Statement from FDA Commissioner on 2019 efforts to advance the development of complex generics to improve patient access to medicines

30 January 2019 - As part of the FDA’s efforts to promote drug competition and patient access, we’ve advanced many ...

Read more →

FDA approves first generic Advair Diskus

30 January 2019 - The U.S. FDA today approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation ...

Read more →

Statement from FDA Commissioner on the agency’s efforts to enhance the utility of the Orange Book to foster drug competition

30 January 2019 - One of our key policy priorities is encouraging the timely development and approval of generics and ...

Read more →

Secretive 'rebate trap' keeps generic drugs for diabetes and other ills out of reach

19 January 2019 - Lisa Crook was lucky. She saved $800 last year after her insurance company started covering a ...

Read more →

FDA approves first generic version of Sabril to help treat seizures in adults and paediatric patients with epilepsy

16 January 2019 - The U.S. FDA approved the first generic version of Sabril (vigabatrin) 500 mg tablets for treating complex ...

Read more →